Skip to main content
. 2025 Jun 15;17(6):104592. doi: 10.4251/wjgo.v17.i6.104592

Table 3.

Comparison of 3-year survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy, n (%)

Group
Number of cases (n)
1 year
2 years
3 years
Effective group 121 113 (93.39) 101 (83.47) 73 (60.33)
Effective group 64 45 (70.31) 23 (35.94) 18 (28.13)
χ² value 7.921 8.691 6.536
P value 0.012 0.004 0.025